Abstract. The hypothalamic-pituitary-adrenal (HPA) axis is susceptible to programming during fetal life. Such programming occurs, at least partially, at the level of the hippocampus. The hippocampus plays a central role in regulation of the HPA axis and release of endogenous glucocorticoids, via mediation of glucocorticoid negative feedback. Fetal exposure to synthetic glucocorticoids can permanently alter glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) levels within the hippocampus, and serotonin is thought to be involved in this process. In the present study, we hypothesised that dexamethasone, cortisol and serotonin exposure would modify GR mRNA expression within fetal guinea-pig hippocampal cultures. Cultures were derived from 40-day-old guinea-pig fetuses, and were exposed to 0, 1, 10 and 100 nm dexamethasone, cortisol or serotonin for 4 days. Expression of GR and MR mRNA was examined by in situ hybridisation followed by high-resolution silver emulsion autoradiography. Four-day exposure to dexamethasone (P < 0.05; 100 nm) or cortisol (P = 0.08; 100 nm) downregulated the expression of GR mRNA within neurons. There was no change in the expression of MR mRNA levels following cortisol treatment. Exposure to serotonin (100 nm) significantly increased GR mRNA levels in hippocampal neurons. We conclude that synthetic and endogenous glucocorticoids, as well as serotonin, can influence GR expression during hippocampal development and in this way may act to permanently programme HPA function.
Introduction
Synthetic glucocorticoid is administered routinely to pregnant women at risk of pre-term delivery. Such treatment is highly effective in preventing respiratory distress syndrome in newborn infants (Ballard 1996) . Until recently, the use of multiple-course glucocorticoid therapy had become common practice in Australia, Europe and North America, if the risk of preterm delivery persisted (Brocklehurst et al. 1999; Smith et al. 2000) . However, following an NIH Consensus Update Conference it was recommended that repeat-course therapy should be confined to ongoing clinical trials until the long-term effects had been established (NIH 2001) . Notwithstanding, this practice in the late 1990s and early 2000s has led to a large cohort of infants and children that received multiple exposure to synthetic glucocorticoids.
It is now well established that hypothalamic-pituitaryadrenal axis (HPA) function can be programmed during development (Levine 1957 (Levine , 1994 . Animal studies indicate that perinatal programming of HPA function involves a permanent resetting of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) levels in the hippocampus, hypothalamus and pituitary (Meaney et al. 2000; Liu et al. 2001; Welberg et al. 2001; Matthews 2002) . In precocious species, such as the guinea-pig, the fetal hippocampus contains high levels of GR and MR. As such, the fetal hippocampus represents a major target for the action of synthetic glucocorticoids. Using the guinea-pig as an in vivo animal model for pregnancy, we have demonstrated previously that prenatal exposure to synthetic glucocorticoid leads to adult offspring with permanently modified HPA function and altered central GR and MR expression, and that this effect is sex specific (Liu et al. 2001) .
Glucocorticoids promote maturation of ascending serotonin systems (Slotkin et al. 1996) and serotonin has been shown to be involved in the development of hippocampal GR systems (Meaney et al. 1994) . Serotonin receptor activation has been shown to increase hippocampal GR in the rat Meaney et al. 2000; Laplante et al. 2002) and mouse in vitro (Erdeljan et al. 2001) . We have shown that this effect is confined to neurons and does not involve changes in glial GR (Erdeljan et al. 2001 ). Meaney and colleagues demonstrated that activation of 5-HT 7 receptor is linked to increased levels of the transcription factor NGFI-A (Meaney et al. 2000) , which in turn interacts with specific GR promoters in rats (Weaver et al. 2001) . However, very little is known concerning the impact of glucocorticoids and serotonin on fetal hippocampal corticosteroid receptor regulation in species that give birth to neuroanatomically mature young (e.g. guinea-pigs or human). We hypothesised that both endogenous (cortisol) and synthetic (dexamethasone) glucocorticoids, and serotonin would directly alter corticosteroid receptor expression in fetal guinea-pig hippocampal neurons, in vitro.
Methods

Fetal guinea-pig cell culture
All animal experiments in the present study were carried out following protocols approved by the Animal Care Committee at the University of Toronto, in accordance with the Canadian Council for Animal Care. Accurately time-dated pregnant guinea-pigs were generated in our laboratory as described previously (Dean and Matthews 1999) . Pregnant animals were killed on Day 40 of gestation (term ∼70 days). Fetal brains were removed rapidly and placed on ice. The hippocampi were isolated from each brain and grouped according to sex. Cultures were generated using a modified version of the Banker technique (Banker and Goslin 1988) . In brief, hippocampi were placed in trypsin/ethylenediaminetetraacetic acid solution (EDTA) (1×) and incubated at 37 • C for 20 min. Trypsin/EDTA was removed and tissue pieces placed in Minimal Essential Medium (MEM)-N2 (1.5 mL); tissue was further processed by trituration. Dissociated tissue was combined with MEM-N2 (1.5 mL, final suspension volume 3 mL). Cell suspension (120 µL) was placed on poly-d-lysine (pH = 8) pre-treated circular coverslips (25 mm) and incubated (37 • C) for 40 min. Coverslips were then transferred into Petri dishes (35 mm) containing mouse cerebellar cells, and suspended with small paraffin supports.
Guinea-pig hippocampal neurons (at Day 40 of gestation (gd40)) are far more mature than hippocampal neurons in late gestation mouse or rat. When guinea-pig neurons were dispersed and cultured, virtually no glial cells remained attached to the coverslips. This necessitated additional neurotrophic support. For this, mouse cerebellar cells were produced from 6-day-old CD1 mice (Charles River Laboratories, St-Constant, QC, Canada). Cerebellar cells were dispersed as described above. Dissociated tissue was suspended in MEM containing fetal bovine serum (FBS) and horse serum (HS). Cell suspension (0.5 mL) was then placed on collagen-coated 35 mm Petri dishes containing MEM with FBS and HS (1 mL). 5 -Fluoro-2 -deoxyuridine (200 µL, 0.02 m; FUDR) was added to each Petri dish 24 h after dissection, to inhibit proliferation and prevent glial overgrowth. Each cerebellar culture was incubated for 5 days before co-incubation with guinea-pig hippocampal cells. Medium was removed from each cerebellar culture and replaced with MEM containing N2 (2.0 mL) 24 h before initiating guinea-pig culture (this was counted as Day 0). Co-cultured cells were allowed to equilibrate for 96 h, after which the medium was changed. On Day 6, medium from culture dishes and coverslips was removed from cerebellar cultures into separate Petri dishes (35 mm), such that the guinea-pig hippocampal neurons remained in cerebellar conditioned media, but not in the same dishes as cerebellar cells. On Day 7, cells were treated with cortisol, dexamethasone (dex) or serotonin (0, 1, 10, 100 nm). Treatment was repeated for 4 days. On Day 12, cells were fixed with paraformaldehyde (4%) and stored in ethanol (95%), at 4 • C, until in situ hybridisation. All chemicals and sera were purchased from Sigma (Oakville, ON, Canada).
In situ hybridisation and emulsion autoradiography
We used a modified method of in situ hybridisation that has been described in detail elsewhere (Matthews et al. 1994; Matthews and Challis 1995) , and utilised oligonucleotide probes characterised previously for GR and MR (Matthews 1998) . Antisense oligonucleotide probes were end-labelled with terminal deoxynucleotydyl transferase (Gibco BRL, Burlington, ON, Canada) and [ 35 S]-deoxyadenosine 5 -(α-thio)triphosphate (4.81 × 10 7 MBq/mmol; NEN, Du Pont Canada, Mississauga, ON, Canada) to a specific activity of 1.0 × 10 9 cpm/µg. Labelled probe in hybridisation buffer (100 µL) was applied to sterile parafilm. Coverslips were then applied to the film and were allowed to incubate overnight at 42 • C. The following day, coverslips were washed in 1 × standard sodium citrate (SSC) (30 min at room temperature) and 1 × SSC (30 min at 55 • C) and then rinsed in 1 × SSC, 0.1 × SSC, 70% ethanol and 95% ethanol. Coverslips were then coated with photographic emulsion (K5, Polysciences, Warrington, PA, USA). Uniform emulsion thickness across the coverslips was achieved by draining and blotting off excess emulsion, and then placing coverslips horizontally on a chilled level metal plate. Once completely dry, coverslips were placed into a light proof box with silica gel and stored at 4 • C. Exposure time was 10 weeks for GR mRNA analysis and 8 weeks for MR mRNA analysis. Several trial exposures were carried out to ensure that emulsions did not become saturated, which could lead to non-linearity of analysis. The emulsions were developed with liquid developer and fixative (Kodak, Rochester, NY, USA). Cells were counterstained with 0.01% methylene blue before mounting.
In situ hybridisation was determined to be the best method of neuronal-specific quantification of mRNA expression rather than other protocols (e.g. real-time polymerase chain reaction) that would not allow separation of mRNA expression in non-neuronal or glial cells. Analysis of neuronal GR mRNA and MR mRNA was carried out at 200× magnification by an operator blinded to treatment. As a consequence of cortisol binding to both GR and MR and because of the labour-intensive nature of these experiments, cells were analysed for both receptors for this treatment only. GR mRNA analysis was undertaken for the dexamethasone and serotonin treatments. Cell counting revealed ∼50 neurons/coverslip. Neurons were first confirmed by counterstaining. Individual grains were identified over ∼20 randomly selected mRNA-positive neurons per culture for each treatment and mean grain count per neuron was calculated for each treatment (four to eight separate cultures per treatment). Each culture was derived from an individual fetus. Due to the nature of our culture technique, non-neuronal cells were present at very low density or were absent altogether, greatly simplifying the grain counting procedure. Background labelling was virtually non-detectable. Grouped data are presented as means ± s.e.m. and were statistically analysed using MANOVA followed by Duncan's posthoc comparison. Data were further collapsed for sex-specific effects and reanalysed.
Results
Specific localisation of silver emulsion grains following in situ hybridisation confirmed the presence of MR and GR mRNA (Fig. 1 ) expression in cultured fetal guinea-pig hippocampal neurons at gd40. Cortisol (100 nm) treatment had no significant effect on MR mRNA expression (Fig. 2) .
Dexamethasone treatment caused a significant reduction (F(3,34) = 4.4389; P < 0.01) in GR mRNA; determined by one-way ANOVA of grouped data (i.e. males and females combined; Fig. 3a) . Post-hoc analysis revealed that this effect was highly significant with the high-dose (100 nm) dexamethasone treatment (F(3,34) = 1.13889; P < 0.05; Fig. 3a) only. Separate sex-specific analysis of cultured cells using two-way ANOVA revealed that the effect of dexamethasone was greater in cultures derived from male fetuses (P < 0.01; Fig. 3b ).
There was a main effect (inhibitory) of cortisol treatment on neuronal GR mRNA levels (F(3,25) = 4.0413; P < 0.02). However, post-hoc analysis failed to identify significance at any specific dose, though there was a strong tendency (P = 0.08) toward cortisol-mediated downregulation of GR mRNA at 100 nm (Fig. 3c) . Two-way ANOVA revealed that the effect of high-dose cortisol (100 nm) tended to be stronger in cultures derived from male fetuses (P = 0.067; Fig. 3d ).
There was a significant effect (F(3,27) = 4.4904; P < 0.01) of serotonin treatment on GR mRNA expression. Post-hoc analysis revealed that while serotonin (1 nm and 10 nm) treatment did not significantly modify GR mRNA expression, at the highest concentration (100 nm), serotonin significantly (F(3,26) = 4.2924; P < 0.02) increased GR mRNA expression (Fig. 4a) . Further, two-way analysis revealed that the increase was only significant in cultures derived from female fetuses (F(3,24) = 2.4777; P < 0.05; Fig. 4b ).
Discussion
The results of the present study demonstrate that glucocorticoid-and serotonin-mediated changes in fetal hippocampal GR mRNA expression in vitro are sex specific. While synthetic glucocorticoid inhibited GR mRNA in hippocampal cells derived at 40 days of gestation, the tendency for downregulation of GR mRNA following treatment with the endogenous glucocorticoid cortisol was specific to malederived cultures. Conversely, serotonin (100 nm) significantly increased GR mRNA cells derived from female fetuses only. Taken together, this is the first study to demonstrate possible sex differences in fetal hippocampal GR mRNA responses to both glucocorticoid and serotonin, in vitro.
Fetal exposure to glucocorticoids programmes long-term HPA activity in rats, guinea-pigs and primates (Uno et al. 1990 (Uno et al. , 1994 Bakker et al. 1995; Levitt et al. 1996; Dean and Matthews 1999) . Exposure of fetal rats to glucocorticoids over the last week of gestation results in adult offspring with increased basal adrenocortical activity and was associated with a hippocampal-specific reduction in both GR and MR mRNA expression (Levitt et al. 1996) . We have previously demonstrated that the HPA axis of the fetal guinea-pig is sensitive to multiple course treatment with dexamethasone, leading to sex-and region-specific changes in fetal guinea-pig hippocampal GR and MR expression (McCabe et al. 2001) . However, repeated exposure to synthetic glucocorticoid failed to acutely downregulate GR mRNA in any region of the fetal hippocampus and dentate gyrus, in vivo (McCabe et al. 2001 ). This contrasted with in vitro studies in the rat and mouse that report both endogenous (corticosterone) and synthetic (dexamethasone) glucocorticoids dose-dependently downregulating hippocampal GR mRNA and binding (Cidlowski and Cidlowski 1981; Vedder et al. 1993; Erdeljan et al. 2000 Erdeljan et al. , 2001 Hery et al. 2000; Semont et al. 2000) . To our knowledge, no studies have investigated hippocampal GR expression acutely in fetal rats whose mothers were treated with glucocorticoid. This disparity in P. Erdeljan et al. results suggests that glucocorticoids differentially affect hippocampal GR expression in vivo and in vitro. We have already demonstrated in our in vivo animal model that synthetic glucocorticoid administered to the pregnant guinea-pig does pass into the fetal brain (McCabe et al. 2001) . Together, these data would suggest additional mechanisms are activated in vivo, which prevent or ameliorate the downregulation of the GR in response to glucocorticoid. The fact that cortisol was less effective at altering GR mRNA expression at equal concentrations to dexamethasone is consistent with the observation that the GR demonstrates increased affinity for synthetic compared to endogenous glucocorticoids (Kraft et al. 1979; Keightley et al. 1998) . Our current finding that treatment with serotonin caused an upregulation of GR mRNA in hippocampal neurons from fetal guinea-pigs is consistent with earlier in vitro studies using hippocampal neurons derived from the fetal mouse and rat Erdeljan et al. 2001) . However, the fact that the effect was confined to hippocampal cultures derived from female fetuses is novel. No previous studies have been undertaken with males and females separated. Sexual differentiation of the guinea-pig brain has been shown to occur between Days 40 and 50 of gestation and it is known that plasma testosterone levels are elevated in male fetuses around this time (Resko and Roselli 1997) . The fact that stimulatory effects of serotonin on hippocampal GR are confined to the female suggests that the signalling mechanism involved might be absent or inhibited in neurons derived from male fetuses. Further studies are clearly required to determine the nature of this interaction.
Recent studies have demonstrated that serotonin exerts its effects on GR transcription via the 5-HT 7 receptor (Laplante et al. 2002) , although other receptors may be involved (Lai et al. 2003) . Meaney et al. (2000) suggested that the interaction between serotonin and glucocorticoid receptor expression is part of a cAMP-sensitive pathway involving actions of the transcription factor NGFI-A. Several reports have shown that thyroid hormone is critical for normal brain maturation, including development of ascending serotonergic systems (Bernal and Nunez 1995; Morreale de Escobar 2001; Chan et al. 2002) . Moreover, modification of thyroid hormone levels in the neonatal rat alters serotonin concentrations in the hippocampus and modifies GR expression (Meaney et al. 2000) . We have previously demonstrated that antenatal treatment with dexamethasone increases fetal thyroxine levels in the fetal guinea-pig (Dean and Matthews 1999) . Therefore, it is possible that maternally administered synthetic glucocorticoid passes into the fetus to affect the hippocampal GR in two ways. First, by direct downregulation of the GR, and second, via activating the thyroid-serotonin pathway leading to an opposing increase in GR. This may result in little net change in the hippocampal GR as we have described, in vivo. It is likely that this balance changes with age and hippocampal development, and definitely warrants further study. The guinea-pig, like the human, gives birth to neuroanatomically mature young (Dobbing and Sands 1970) , and therefore it is possible that synthetic glucocorticoids have similar effects in the fetal human brain. This is particularly important as women at perceived risk of preterm labour will, along with their fetuses, be exposed to high doses of synthetic glucocorticoid during the second half of gestation. The fact that the fetal hippocampal GR does not downregulate in response to high levels of synthetic glucocorticoid in vivo suggests that this structure may be vulnerable to the detrimental effects of excessive glucocorticoid exposure. With respect to direct actions of serotonin, antidepressant intake during pregnancy may likely change extracellular serotonin levels in the fetal hippocampus, which may in turn modify developmental trajectory of the hippocampal GR system. In support of the effects of serotonin on GR, recent studies have shown that treatment of fetal rat hippocampal neurons with antidepressants in vitro can selectively increase GR mRNA expression (Yau et al. 2002) and increase GR-mediated gene transcription (Pariante et al. 2001; Herr et al. 2003) . It is difficult to speculate in detail how our current in vitro results relate to the situation in vivo following maternal treatment with synthetic glucocorticoid or antidepressants. However, we have determined that at high concentrations, glucocorticoids do have the ability to downregulate (autoregulate) GR mRNA in hippocampal neurons (derived at 40 days of gestation) and that the cellular machinery is present in the hippocampal neurons to allow serotonin to directly upregulate GR mRNA. To our knowledge, no studies have investigated the concentration of synthetic glucocorticoids in the fetal hippocampus following maternal treatment and further research is required to link the in vitro mechanistic information with the situation in vivo. It is also important to note that while the magnitude of the effects of glucocorticoids and serotonin on GR mRNA (∼25% change) are modest, previous studies have shown this level of effect to be biologically significant. Specifically, variations (25%) in corticosteroid receptor mRNA associated with stage of the reproductive and diurnal cycles have been shown to be mirrored by receptor binding in adult rats (Carey et al. 1995) . Further studies are required to determine whether such a relationship exists in the fetus.
In summary, this study has demonstrated that synthetic glucocorticoid and serotonin exert specific effects on GR mRNA in cultured guinea-pig hippocampal neurons. This supports the notion that exposure to glucocorticoid or serotonin may exert long-term influences on the development and subsequent function of the HPA axis.
